Drawing for CELLFX

USPTO serial 87748866

CELLFX

Reviewed by CopyMark Law Group

Reg. 6348388Status 700Renewal
Filing date
Status date
Registration date
May 11, 2021
Examiner
BLANDU, FLORENTINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CELLFX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lena Vinitskaya

3957 POINT EDEN WAYHAYWARD, CA 94545

Goods and services

ClassDescriptionStatusFirst use
044Oncology, immunology and dermatology services using electric pulse technology; cosmetic medical services, namely, services for tissuemanipulation and modification; providing information in the field of oncology and medical and cosmetic tissue modification, manipulationand/or ablation using electric pulse technology; immunotherapeutic services for treating medical conditions; medical assistance servicesprovided through use of short electric pulses, including nanopulse electricity, for human and animal biomedical applications, including for theprevention, detection, diagnosis and treatment of medical conditions, diseases and injuries; medical assistance services through use ofnanopulse technology for ablation, manipulation or modification of biologic tissue; medical assistance services, namely, use of electric pulsetechnology for treatment of tumors, tissue growth, skin growth, warts, papilloma, and other medical conditions and disease, all of whichexclude services related to treatment of celluliteACTIVEFeb 12, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 11, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 11, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 8, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 7, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 25, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 24, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 24, 2021EX4GSOU EXTENSION 4 GRANTED—
Mar 18, 2021IUAFUSE AMENDMENT FILED—
Mar 18, 2021EXT4SOU EXTENSION 4 FILED—
Mar 18, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 18, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 15, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 12, 2020EX3GSOU EXTENSION 3 GRANTED—
Sep 12, 2020EXT3SOU EXTENSION 3 FILED—
Sep 12, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 19, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 17, 2020EX2GSOU EXTENSION 2 GRANTED—
Mar 17, 2020EXT2SOU EXTENSION 2 FILED—
Mar 17, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 10, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 10, 2019NOACCORRECTED NOA E-MAILED—
Oct 9, 2019EX1GSOU EXTENSION 1 GRANTED—
Oct 9, 2019DPCCDIVISIONAL PROCESSING COMPLETE—
Sep 5, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 4, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 29, 2019EXT1SOU EXTENSION 1 FILED—
Aug 29, 2019DRRRDIVISIONAL REQUEST RECEIVED—
Aug 29, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 29, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 24, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 26, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 13, 2019ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Feb 4, 2019CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Feb 1, 2019APETASSIGNED TO PETITION STAFF—
Jan 23, 2019EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Oct 9, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 11, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 11, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 22, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 9, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 9, 2018DOCKASSIGNED TO EXAMINER—
Jul 2, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 2, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 28, 2018ALIEASSIGNED TO LIE—
Jun 13, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2018DOCKASSIGNED TO EXAMINER—
Jan 23, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 12, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance